Announcements Trials
Browse Landscape

Status

Completed 11Terminated 3Withdrawn 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 4Genitourinary 3Other hematologic neoplasm 2CNS 2Breast 2Thoracic 1Sarcoma 1Plasma cell 1Myeloid 1Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Uterine Cervical Neoplasms 1Anus Neoplasms 1

Interventions

Oxaliplatin 197Bevacizumab 161Fluorouracil 154Capecitabine 137Gemcitabine 134Leucovorin 111pembrolizumab 99Cisplatin 94Drug Therapy 89Irinotecan 80Radiotherapy 73sintilimab 70130-nm albumin-bound paclitaxel 66durvalumab 65Paclitaxel 64Specimen Handling 62Cetuximab 61lenvatinib 59tislelizumab 58Nivolumab 55Magnetic Resonance Spectroscopy 55Folfox protocol 55Blood Specimen Collection 52atezolizumab 47Biopsy 46Surgical Procedures, Operative 40Taxes 39Albumin-Bound Paclitaxel 39Immune Checkpoint Inhibitors 37HMPL-013 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Positron-Emission Tomography × Gastrointestinal × Clear all
NCT04857528 2026-03-04

Detecting HPV DNA in Anal and Cervical Cancers

University of Chicago

Recruiting
20 enrolled
GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡